Skip to content

Research at St Andrews

Cyclic oligoadenylate signalling mediates Mycobacterium tuberculosis CRISPR defence

Research output: Contribution to journalArticle

DOI

Open Access permissions

Open

Author(s)

Sabine Grüschow, Januka S Athukoralage, Shirley Graham, Tess Hoogeboom, Malcolm F White

School/Research organisations

Abstract

The CRISPR system provides adaptive immunity against mobile genetic elements (MGE) in prokaryotes. In type III CRISPR systems, an effector complex programmed by CRISPR RNA detects invading RNA, triggering a multi-layered defence that includes target RNA cleavage, licencing of an HD DNA nuclease domain and synthesis of cyclic oligoadenylate (cOA) molecules. cOA activates the Csx1/Csm6 family of effectors, which degrade RNA non-specifically to enhance immunity. Type III systems are found in diverse archaea and bacteria, including the human pathogen Mycobacterium tuberculosis. Here, we report a comprehensive analysis of the in vitro and in vivo activities of the type III-A M. tuberculosis CRISPR system. We demonstrate that immunity against MGE may be achieved predominantly via a cyclic hexa-adenylate (cA6) signalling pathway and the ribonuclease Csm6, rather than through DNA cleavage by the HD domain. Furthermore, we show for the first time that a type III CRISPR system can be reprogrammed by replacing the effector protein, which may be relevant for maintenance of immunity in response to pressure from viral anti-CRISPRs. These observations demonstrate that M. tuberculosis has a fully-functioning CRISPR interference system that generates a range of cyclic and linear oligonucleotides of known and unknown functions, potentiating fundamental and applied studies.
Close

Details

Original languageEnglish
Pages (from-to)9259-9270
Number of pages12
JournalNucleic Acids Research
Volume47
Issue number17
Early online date8 Aug 2019
DOIs
Publication statusPublished - 26 Sep 2019

    Research areas

  • Crystal-structure, DNA cleavage, CMS complex, Protein, Degradation, Immunity, System, CSX1

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. A viral ring nuclease anti-CRISPR subverts type III CRISPR immunity

    Athukoralage, J. S., McMahon, S., Zhang, C., Gruschow, S., Graham, S., Krupovic, M., Whitaker, R., Gloster, T. & White, M., 14 Nov 2019, (Accepted/In press) In : Nature. in press

    Research output: Contribution to journalArticle

  2. A type III CRISPR ancillary ribonuclease degrades its cyclic oligoadenylate activator

    Athukoralage, J. S., Graham, S., Grüschow, S., Rouillon, C. & White, M. F., 12 Jul 2019, In : Journal of Molecular Biology. 431, 15, p. 2894-2899

    Research output: Contribution to journalArticle

  3. Investigation of the cyclic oligoadenylate signaling pathway of type III CRISPR systems

    Rouillon, C., Athukoralage, J. S., Graham, S., Grüschow, S. & White, M. F., 1 Jan 2019, Methods in Enzymology. Bailey, S. (ed.). Academic Press Inc., p. 191-218 28 p. (Methods in Enzymology; vol. 616).

    Research output: Chapter in Book/Report/Conference proceedingChapter

  4. Ring nucleases deactivate Type III CRISPR ribonucleases by degrading cyclic oligoadenylate

    Athukoralage, J. S., Rouillon, C., Graham, S., Grüschow, S. & White, M. F., 11 Oct 2018, In : Nature. 562, 7726, p. 277-280 16 p.

    Research output: Contribution to journalArticle

  5. Control of cyclic oligoadenylate synthesis in a type III CRISPR system

    Rouillon, C., Athukoralage, J. S., Graham, S., Grüschow, S. & White, M. F., 19 Jul 2018, In : eLife. 7, 22 p., e36734.

    Research output: Contribution to journalArticle

Related by journal

  1. The ATP-dependent chromatin remodelling enzyme Uls1 prevents Topoisomerase II poisoning

    Swanston, A., Zabrady, K. & Ferreira, H. C., 9 Jul 2019, In : Nucleic Acids Research. 47, 12, p. 6172–6183 12 p.

    Research output: Contribution to journalArticle

  2. Unprecedented tunability of riboswitch structure and regulatory function by sub-millimolar variations in physiological Mg2+

    McCluskey, K. A., Boudreault, J., St-Pierre, P., Perez Gonzalez, C., Chauvier, A., Rizzi, A., Beauregard, P. B., Lafontaine, D. A. & Penedo-Esteiro, J. C., 9 Jul 2019, In : Nucleic Acids Research. 47, 12, p. 6478–6487 10 p.

    Research output: Contribution to journalArticle

  3. Insights into the evolutionary conserved regulation of Rio ATPase activity

    Knüppel, R., Christensen, R., Gray, F. C., Esser, D., Strauss, D., Medenbach, J., Siebers, B., MacNeill, S. A., LaRonde, N. & Ferreira-Cerca, S., 16 Feb 2018, In : Nucleic Acids Research. 46, 3, p. 1441-1456 16 p.

    Research output: Contribution to journalArticle

  4. Prespacer processing and specific integration in a Type I-A CRISPR system

    Rollie, C., Graham, S., Rouillon, C. & White, M. F., 16 Feb 2018, In : Nucleic Acids Research. 46, 3, p. 1007-1020 14 p.

    Research output: Contribution to journalArticle

ID: 261681537

Top